Skip to main content
IEX logo

IEX · Idex Corp

Track IEX — free
$233.14 +0.55 (+0.24%) At close · Nov 18
Market Cap
$17.12B
Shares
73.45M
Volume · Nov 18 428.07K Avg daily vol (3M) 675.64K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$233.14 Open$231.48 Day$231.48–234.42 52W close$161.68–240.52 Avg vol 30d760K Short int2.4M · 3.3% of shares · 2.8d Short vol44% Last earningsOct 28, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 28

Up next

Feb 3, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 16
Investor event
Advantage markets grew close to 50%, supporting double digits EPS

IDEX said data centers, semiconductor and space and defense grew close to 50% year to date; mid single digit plus organic growth and mid to high 30s flow through support double digits EPS, with a $75 million a quarter repurchase run rate.

5 source passages
And those three areas of the company, we mentioned on the Q3 earnings call year-to-date, have been growing close to 50%. And within that, as you'd probably expect, data centers punching above that 50%, semiconductor probably kind of right on it, and then space and defense a little bit below. You start to get, if you do the math on what we've laid out, kind of Eric at the top line talking about mid single digit plus on organic growth. And when you have flow through in the mid to high 30s, you know, all the other variables equal, you start to get into the double digits from an EPS growth standpoint. So the run rate today is about $75 million a quarter. And that's probably the base case for the time being. So for IDEX, it's being counterbalanced on the negative side with kind of a big platform that we have that's sunsetting off. Open the document at this passage
Oct 28
Earnings call
Raises 2026 outlook after record Q3 sales and adjusted EPS

IDEX reported record Q3 sales and adjusted EPS, with organic sales up 8% and adjusted EPS up 15% to $2.33. Orders grew 13% organically to nearly $1 billion. The company raised its full-year 2026 outlook, now expecting organic growth of 6.5% to 6.8%.

7 source passages
We are raising our full-year 2026 outlook due to the strong Q3 results and are expecting to close out the year with momentum. Sales and adjusted EPS were both records. Organic sales grew 8%, with HST up 13%, FMT up 4%, and FSDP up 6%. IDEX delivered another strong quarter, with Q3 results ahead of our expectations on sales, margins, and earnings. orders were again a highlight in the quarter, growing 13% year-over-year, reaching nearly $1 billion. We now expect organic growth of 6.5% to 6.8%, up from 5% to 6%. adjusted EPS grew 15% to $2.33. Open the document at this passage
Oct 28
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Third-quarter sales rose 8%, adjusted EPS increased 15%

IDEX reported third-quarter 2026 net sales of $951.7 million, up 8%, and adjusted diluted EPS of $2.33, up 15%. It returned $74.6 million through share repurchases and $54.0 million in dividends.

Revenue $951.7M ▲ 8.3% Net income $144.1M ▲ 12.8% Diluted EPS $1.95 ▲ 14.7%
Read from the MD&A section
4 source passages
Three Months Ended September 30, 2026 Net sales of $951.7 million increased 8% on both a reported basis and organically* Adjusted diluted EPS attributable to IDEX\* of $2.33 increased 15% Returned capital to shareholders in the form of $74.6 million of share repurchases and $54.0 million of dividends Open the document at this passage
Oct 28
Current report 8-K
Record third-quarter sales of $952 million; full-year guidance raised

IDEX reported record sales of $952 million for the third quarter, up 8% on both a reported and organic basis, with adjusted diluted EPS of $2.33, up 15%. It raised its full-year organic sales growth projection to 6.5% to 6.8%, up from 5% to 6%. Full-year adjusted diluted EPS guidance rose to $8.91 to $8.96 from $8.70 to $8.85.

Financial results
5 source passages
IDEX REPORTS RECORD THIRD QUARTER RESULTS Record sales of $952 million increased 8% on both a reported and organic basis Reported diluted EPS of $1.95 and record adjusted diluted EPS of $2.33 both increased 15% Full year organic sales projected to increase 6.5% to 6.8% over the prior year, up from previous guidance of 5% to 6% Full year adjusted diluted EPS of $8.91 to $8.96, up approximately 12% year-over-year at midpoint, up from previous guidance of $8.70 to $8.85 Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.66B
Trailing 12 months
Net income (TTM)
$535.80M
Trailing 12 months
Revenue growth YoY
+8.3%
Year over year
Operating margin
20.9%
Trailing 12 months
P / E (TTM)
32.4
Trailing earnings · reciprocal yield 3.1%
FCF yield
3.9%
TTM · current market cap
Return on invested capital
11.3%
Trailing 12 months
Net cash
−$1.15B
Latest balance sheet
Dividend yield
1.2%
Trailing 12 months
Shares change YoY
-1.6%
Year over year · fewer shares
Price change (1Y)
+44.2%
Trailing year
Short interest
3.3%
Latest settlement · 2.8 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Oct 28, 2026
Q3 FY26

TL;DR. IDEX reported record third-quarter sales and adjusted EPS, 8% organic sales growth, 13% order growth, 15% adjusted EPS growth and margin expansion; management raised full-year organic growth and adjusted EPS guidance while tightening adjusted EBITDA margin guidance to 27.1%–27.3%. Risks include inflation and price/cost pressure, sequential order declines and lumpy data-center demand, an expected fourth-quarter margin step-down, continued weakness in chemical, agriculture and energy volumes, flat life-sciences growth, and higher corporate costs.

Bullish
  • + Third-quarter sales, orders, adjusted EPS, margins and earnings exceeded guidance, with record sales and adjusted EPS.
  • + Management raised full-year organic growth and adjusted EPS guidance and tightened the adjusted EBITDA margin outlook.
Bearish
  • − Stubborn inflation and elevated energy prices continued to increase input costs and create price/cost headwinds.
  • − Fourth-quarter margins are expected to step down sequentially because of fewer production days and planned maintenance shutdowns that lower sales and margin.
  • − Chemical, agriculture and energy businesses continued to experience lower volumes.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Fair Quant / Vol Very Low
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +7%
above
Price vs 50-day avg +1%
above
RSI (14) 49
neutral
MACD trend Negative
52-week position 91%
near high
Momentum
relative strength
Very Strong
1-month return −1%
trailing
6-month return +11%
trailing
YTD return +31%
this year
Relative strength +14%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $232 › 200d $219 — 50d above 200d
Institutional flow Accumulating
+5% holders QoQ · +96 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.26% of shares out · ▼ -3.5% MoM · 2.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
733 holders — near 3-yr high, broad support
Squeeze score 56
elevated · 0–100
Fundamentals
Fair
Revenue growth +6%
Y/Y
Gross margin 45%
expanding
EPS growth −3%
Y/Y
Free cash flow $616.8M
Valuation P/E 32.4
in line
Buyback $699.7M
remaining
Balance sheet $1.2B
net debt
Quant / Vol
risk profile
Very Low
Volatility 23%
annualized · 1-yr
Max drawdown −14%
past year
ATR 2.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 5 of last 8
Latest guidance · from the 8-K filed Oct 28, 2026
Full year organic sales · Full year Non-GAAP Raised 6.5% – 6.8%
Apr 29, 2026 3% – 4% changed to Oct 28, 2026 6.5% – 6.8%
Full year adjusted diluted EPS · Full year Non-GAAP Raised $8.91 – $8.96
Jul 29, 2026 $8.70 – $8.85 changed to Oct 28, 2026 $8.91 – $8.96
Previous outlook earlier release · from the Earnings Call filed Jul 29, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted EBITDA margin · full year 2026 27% – 27.3%
Capital expenditures · full year 2026 $110M
Organic growth · full year 2026 5% – 6%
Prior guidance period ended · from the Earnings Call filed Jul 29, 2026
Adjusted EBITDA margin · third quarter of 2026 27% – 27.5%
Adjusted EPS · third quarter of 2026 $2.20 – $2.25
Organic growth · third quarter of 2026 5% – 7%
Guided vs delivered · last 8 settled
GAAP diluted EPS Full Year 2024
guided $6.85 – $6.95
$6.64 Miss −3.8%
GAAP diluted EPS Third Quarter 2024
guided $1.61 – $1.66
$1.57 Miss −4.0%
GAAP diluted EPS Second Quarter 2024
guided $1.75 – $1.80
$1.86 Beat +4.8%
GAAP diluted EPS First quarter 2024
guided $1.45 – $1.50
$1.60 Beat +8.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+7% Bullish
Price vs 50-day avg
+1% Bullish
RSI (14)
49 Neutral
MACD trend
Negative Bearish
52-week position
91% Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $232 › 200d $219 — 50d above 200d
Institutional flow Accumulating
+5% holders QoQ · +96 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.26% of shares out · ▼ -3.5% MoM · 2.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
733 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $162 Now $233 · 91% Range high $241
vs 200-day avg +7% vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Specialty Industrial Machinery — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IEX
Idex Corp
this stock
$17.12B +31.0% +5.8% 32.4 3.3%
GEV
GE Vernova Inc.
$204.39B +18.2% +9.0% 20.3 2.8%
ETN
Eaton Corp plc
$131.45B +6.2% +10.3% 33.8 1.8%
SMERY
Siemens Energy AG
$118.31B — — — 0.0%
PH
Parker-Hannifin Corp
$115.86B +4.5% +18.9% 31.6 1.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
733
% held
97.8%
Net QoQ
-3.1M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
683
View
Short & Settlement
Short Interest Falling
Shares short
2.4M
Days to cover
2.8d
Change
-88.2K sh
View
Short Volume
Short vol %
44%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
430
Value
$98.5K
As of
Oct 26, 2026
View
Off-Exchange
Off-exchange %
41.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Oct 31, 2025
View
Financials
Financials
Revenue (FY)
$3.5B
Net income (FY)
$483.2M
EPS diluted
$6.41
View
Buybacks
Remaining
$699.7M
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Nov 16, 2026
This year
18

IDEX said data centers, semiconductor and space and defense grew close to 50% year to date; mid single digit plus organic growth and mid to high 30s flow through support double digits EPS, with a $75 million a quarter repurchase run rate.

View
Proposed Sales
Value
$91.8K
Shares
385
Filed
Aug 12, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 8, 2026
Last webcast
Nov 16, 2026
View
Investor Relations
Latest news
IDEX Corporation Declares Regular…
Published
Nov 11, 2026
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
IEX -2.8% -1.0% +10.6% -0.3% +31.0%
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY +1.1% +4.6% +14.1% +3.1% +23.9%

Capital returns

Latest dividend
$0.73 / share · ex Oct 2, 2026
Declared · upcoming
$0.73 / share · ex Jan 13, 2027
Raised 2.8%
Paid (TTM)
$2.90 / share · 4 payouts
Dividend yield (TTM, derived)
1.24%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
—
Spent (derived)
—
Remaining
$699.70M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 832101 CUSIP 45167R104 13F (30d) 697 filings 654 filers Visit website Investor relations